Genomic Analyses of Longitudinal Mycobacterium abscessus Isolates in a Multicenter Cohort Reveal Parallel Signatures of In-Host Adaptation.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
    • Publication Information:
      Publication: Jan. 2011- : Oxford : Oxford University Press
      Original Publication: 1904-2010 : Chicago, IL : University of Chicago Press
    • Subject Terms:
    • Abstract:
      Background: Nontuberculous mycobacteria (NTM) are ubiquitous in the environment and an increasingly frequent cause of opportunistic infections. Mycobacterium abscessus complex (MABC) is one of the major NTM lung pathogens that disproportionately colonize and infect the lungs of individuals with cystic fibrosis (CF). MABC infection can persist for years, and antimicrobial treatment is frequently ineffective.
      Methods: We sequenced the genomes of 175 isolates longitudinally collected from 30 patients with MABC lung infection. We contextualized our cohort amidst the broader MABC phylogeny and investigated genes undergoing parallel adaptation across patients. Finally, we tested the phenotypic consequences of parallel mutations by conducting antimicrobial resistance and mercury-resistance assays.
      Results: We identified highly related isolate pairs across hospital centers with low likelihood of transmission. We further annotated nonrandom parallel mutations in 22 genes and demonstrated altered macrolide susceptibility co-occurring with a nonsynonymous whiB1 mutation. Finally, we highlighted a 23-kb mercury-resistance plasmid whose loss during chronic infection conferred phenotypic susceptibility to organic and nonorganic mercury compounds.
      Conclusions: We characterized parallel genomic processes through which MABC is adapting to promote survival within the host. The within-lineage polymorphisms we observed have phenotypic effects, potentially benefiting fitness in the host at the putative detriment of environmental survival.
      Competing Interests: Potential conflicts of interest. All authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
      (© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: [email protected].)
    • References:
      PLoS Pathog. 2015 Dec 31;11(12):e1005258. (PMID: 26719892)
      Clin Infect Dis. 2020 Apr 15;70(9):1855-1864. (PMID: 31225586)
      Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416. (PMID: 17277290)
      Nat Commun. 2017 Dec 22;8(1):2280. (PMID: 29273788)
      Nat Biotechnol. 2000 Feb;18(2):213-7. (PMID: 10657131)
      Lancet Microbe. 2021 Oct;2(10):e498-e507. (PMID: 34632432)
      Sci Rep. 2022 Sep 27;12(1):16116. (PMID: 36167715)
      J Cyst Fibros. 2020 Mar;19(2):219-224. (PMID: 30853372)
      Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19126-31. (PMID: 19855009)
      Am J Respir Crit Care Med. 2003 Mar 15;167(6):828-34. (PMID: 12433668)
      Korean J Intern Med. 1998 Jul;13(2):127-30. (PMID: 9735669)
      Lancet Respir Med. 2017 Jan;5(1):15. (PMID: 27956215)
      Front Pharmacol. 2021 Dec 08;12:790767. (PMID: 34955859)
      Lancet. 2013 May 4;381(9877):1551-60. (PMID: 23541540)
      J Antimicrob Chemother. 2012 Apr;67(4):810-8. (PMID: 22290346)
      Microbiology (Reading). 2006 Jun;152(Pt 6):1581-1590. (PMID: 16735722)
      Microbiome. 2017 Feb 10;5(1):20. (PMID: 28187782)
      Clin Chest Med. 2002 Sep;23(3):529-51. (PMID: 12370991)
      Virulence. 2021 Dec;12(1):2415-2429. (PMID: 34546836)
      FEMS Microbiol Rev. 2003 Jun;27(2-3):355-84. (PMID: 12829275)
      Clin Dev Immunol. 2011;2011:497203. (PMID: 21318182)
      mSystems. 2020 Jun 23;5(3):. (PMID: 32576651)
      Nat Genet. 2014 Jan;46(1):82-7. (PMID: 24316980)
      Science. 2016 Nov 11;354(6313):751-757. (PMID: 27846606)
      Trends Microbiol. 2010 Mar;18(3):117-23. (PMID: 20060723)
      Science. 2021 Apr 30;372(6541):. (PMID: 33926925)
      J Clin Microbiol. 2001 Feb;39(2):816-9. (PMID: 11158161)
      J Bacteriol. 2009 Jan;191(1):439-44. (PMID: 18931130)
      Antimicrob Agents Chemother. 1991 May;35(5):819-23. (PMID: 1854163)
      Clin Infect Dis. 2015 Apr 1;60(7):1007-16. (PMID: 25452595)
      Thorac Surg Clin. 2019 Feb;29(1):95-108. (PMID: 30454926)
      Antimicrob Agents Chemother. 2017 Oct 24;61(11):. (PMID: 28874378)
      Microorganisms. 2019 Mar 22;7(3):. (PMID: 30909391)
      Annu Rev Microbiol. 1986;40:607-34. (PMID: 3535655)
      Dent Mater. 2001 Mar;17(2):95-101. (PMID: 11163377)
      Acta Trop. 2019 Sep;197:105041. (PMID: 31152726)
      PLoS One. 2013 May 16;8(5):e63237. (PMID: 23696800)
      Am J Respir Crit Care Med. 2003 Mar 15;167(6):810-2. (PMID: 12623856)
      Ann Am Thorac Soc. 2021 Dec;18(12):1960-1969. (PMID: 33856965)
      J Clin Microbiol. 2022 Jan 19;60(1):e0154721. (PMID: 34705540)
      Clin Infect Dis. 2017 Apr 01;64(7):902-911. (PMID: 28077517)
      Cell. 2022 May 26;185(11):1860-1874.e12. (PMID: 35568033)
      J Clin Lab Anal. 2016 Sep;30(5):751-5. (PMID: 27169515)
      Emerg Infect Dis. 2008 Mar;14(3):378-84. (PMID: 18325250)
      Nat Rev Microbiol. 2020 Jul;18(7):392-407. (PMID: 32086501)
      J Pathog. 2015;2015:809014. (PMID: 26618006)
    • Grant Information:
      T32 CA113275 United States CA NCI NIH HHS; R01 OH011578 United States OH NIOSH CDC HHS; K23 HL136934 United States HL NHLBI NIH HHS; P30 CA091842 United States CA NCI NIH HHS; R01 AI123394 United States AI NIAID NIH HHS; U01 AI123394 United States AI NIAID NIH HHS
    • Contributed Indexing:
      Keywords: Mycobacterium abscessus complex; comparative genomics; in-host adaptation; nontuberculous mycobacteria
    • Accession Number:
      H1250JIK0A (Clarithromycin)
      0 (Anti-Bacterial Agents)
    • Publication Date:
      Date Created: 20230531 Date Completed: 20230814 Latest Revision: 20240601
    • Publication Date:
      20240601
    • Accession Number:
      PMC10420398
    • Accession Number:
      10.1093/infdis/jiad187
    • Accession Number:
      37254795